VANGUARD GROUP INC 13D and 13G filings for ADMA Biologics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 3:12 pm Sale | 2026-03-13 | 13G | ADMA BIOLOGICS INC ADMA | VANGUARD GROUP INC | 0 0.000% | -21,363,715 (Position Closed) | Filing |
| 2025-07-29 11:22 am Purchase | 2025-06-30 | 13G | ADMA BIOLOGICS INC ADMA | VANGUARD GROUP INC | 21,363,715 8.940% | 3,245,221 (+17.91%) | Filing |
| 2024-11-12 1:34 pm Unchanged | 2024-09-30 | 13G | ADMA BIOLOGICS INC ADMA | VANGUARD GROUP INC | 18,118,494 7.770% | 0 (Unchanged) | Filing |
| 2024-11-04 11:00 am Purchase | 2024-09-30 | 13G | ADMA BIOLOGICS INC ADMA | VANGUARD GROUP INC | 18,118,494 7.770% | 5,226,619 (+40.54%) | Filing |
| 2024-02-13 4:56 pm Purchase | 2023-12-29 | 13G | ADMA BIOLOGICS INC ADMA | VANGUARD GROUP INC | 12,891,875 5.710% | 12,891,875 (New Position) | Filing |